Poly(L-histidine)-tagged 5-aminolevulinic acid prodrugs: New photosensitizing precursors of protoporphyrin IX for photodynamic colon cancer therapy

International Journal of Nanomedicine

Volumn 7, Issue , 2012, Pages 2497-2512

  Johnson, Renjith P ^a   Chung, Chung Wook ^b   Jeong, Young Il ^b   Kang, Dae Hwan ^b   Suh, Hongsuk ^a   Kim, Il ^a  

^a Pusan National University   (South Korea)

^b Pusan National University Yangsan Hospital   (South Korea)

Author keywords

5 aminolevulinic acid; Bioconjugate; Cancer cells; Photodynamic therapy; Poly(L histidine)

Indexed keywords

ACID ANHYDRIDE; AMINOLEVULINIC ACID; POLYHISTIDINE TAG; PRODRUG; PROTOPORPHYRIN;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER THERAPY; CELL STRAIN HCT116; CELL SURVIVAL; CELL VIABILITY; CELLULAR DISTRIBUTION; COLON CANCER; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG EFFECT; DRUG EFFICACY; DRUG SCREENING; DRUG STRUCTURE; FLUORESCENCE ANALYSIS; HUMAN; HUMAN CELL; PH MEASUREMENT; PHOTODYNAMIC THERAPY; PHOTOSENSITIZATION; PHOTOTOXICITY; PHYSICAL CHEMISTRY; POLYMERIZATION; SENSITIVITY ANALYSIS;

AMINOLEVULINIC ACID; APOPTOSIS; CELL SURVIVAL; COLONIC NEOPLASMS; FLOW CYTOMETRY; HCT116 CELLS; HEK293 CELLS; HISTIDINE; HUMANS; HYDROGEN-ION CONCENTRATION; MODELS, MOLECULAR; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PRODRUGS; PROTOPORPHYRINS;

EID: 84870307769     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S29582     Document Type: Article

References (45)

1. Barbara K, Kristjan P. ALA and its clinical impact, from bench to bedside. Photochem Photobiology Sci. 2008;7(3):283-289.
2. James CK, Pottier RH. New trends in photobiology: endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy. J Photochem Photobiol B. 1992;14(4):275-292.
3. Kennedy JC, Pottier RH, Pross DC. Photodynamic therapy with endogenous protoporphyrin: IX: basic principles and present clinical experience. J Photochem Photobiol B. 1990;6(1-2):143-148.
4. Blume JE, Oseroff AR. Aminolevulinic acid photodynamic therapy for skin cancers. Dermatol Clin. 2007;25(1):5-14.
5. Peng Q, Warloe T, Moan J, et al. Distribution of 5-aminolevulinic acid-induced porphyrins in noduloulcerative basal cell carcinoma. Photochem Photobiol. 1995;62(5):906-913.
6. Kloek J, Beijersbergen VH. Prodrugs of 5-aminolevulinic acid for photodynamic therapy. Photochem Photobiol. 1996;64(6):994-1000.
7. Gaullier JM, Berg K, Peng Q. Use of 5-aminolevulinic acid esters to improve photodynamic therapy on cells in culture. Cancer Res. 1997; 57(8):1481-1486.
8. Uehlinger P, Zellweger M, Wagnieres G. 5-aminolevulinic acid and its derivatives: physical chemical properties and protoporphyrin IX formation in cultured cells. J Photochem Photobiol B. 2000;54(1): 72-80.
9. Berger Y, Greppi A, Siri O, et al. Ethylene glycol and amino acid derivatives of 5-aminolevulinic acid as new photosensitizing precursors of protoporphyrin IX in cells. J Med Chem. 2000;43(25):4738-4746.
10. Battah SH, Chee CE, Nakanishi H. Synthesis and biological studies of 5-aminolevulinic acid-containing dendrimers for photodynamic therapy. Bioconjug Chem. 2001;12(6):980-988.
11. Di Venosa GM, Casas AG, Battah S. Investigation of a novel dendritic derivative of 5-aminolaevulinic acid for photodynamic therapy. Int J Biochem Cell Biol. 2006;38(1):82-91.
12. Battah S, O'Neill S, Edwards C. Enhanced porphyrin accumulation using dendritic derivatives of 5-aminolaevulinic acid for photodynamic therapy: an in vitro study. Int J Biochem Cell Biol. 2006;38(8): 1382-1392.
13. Casas A, Perotti C, Saccoliti M. ALA and ALA hexyl ester in free and liposomal formulations for the photosensitization of tumor organ cultures. Br J Cancer. 2002;86(8):837-842.
14. Casas A, Batlle A. Aminolevulinic acid derivatives and liposome delivery as strategies for improving 5-aminolevulinic acid-mediated photodynamic therapy. Curr Med Chem. 2006;13(10):1157-1168.
15. Webber J, Kessel D, Fromm D. Side effects and photosensitization of human tissues after aminolevulinic acid. J Surg Res. 1997;68(1):31-37.
16. Casas A, Batlle A, Butler A, et al. Comparative effect of ALA derivatives on protoporphyrin IX production in human and rat skin organ cultures. Br J Cancer. 1999;80(10):1525-1532.
17. Berger Y, Ingrassia L, Neier R, Juillerat-Jeanneret L. Evaluation of dipeptide-derivatives of 5-aminolevulinic acid as precursors for photosensitizers in photodynamic therapy. Bioorg Med Chem. 2003;11(7): 1343-1351.
18. Ludovic BF, Giuntini I, Eggleston M, et al. 5-Aminolevulinic acid peptide prodrugs enhance photosensitization for photodynamic therapy. Mol Cancer Ther. 2008;7(6):1720-1729.
19. Giuntini F, Bourre L, MacRobert AJ, et al. Improved peptide prodrugs of 5-ALA for PDT: rationalization of cellular accumulation and protoporphyrin IX production by direct determination of cellular prodrug uptake and prodrug metabolization. J Med Chem. 2009;52(13):4026-4037.
20. Zhu X, Lu W, Zhang Y, et al. Imidazole-modified porphyrin as a pHresponsive sensitizer for cancer photodynamic therapy. Chem Commun (Camb). 2011;47(37):10311-10313.
21. Pichon C, Goncalves C, Midoux P. Histidine-rich peptides and polymers for nucleic acids delivery. Adv Drug Deliv Rev. 2001;53(1-3):75-94.
22. Benns JM, Choi JS, Mahato RI, et al. pH-sensitive cationic polymer gene delivery vehicle: N-Ac-poly(L-histidine)-graft-poly(L-lysine) comb shaped polymer. Bioconjug Chem. 2000;11(5):637-645.
23. 3 approach. J Chem Phys. 2000;113(18):7756-7764.
24. Klamt A, Schüürmann G. COSMO: a new approach to dielectric screening in solvents with explicit expressions for the screening energy and its gradient. J Chem Soc Perkin Trans. 1993;2(6):799-805.
25. Andzelm J, Kolmel C, Klamt A. Incorporation of solvent effects into the density functional calculations of molecular energies and geometries. J Chem Phys. 1995;103(21):9312-9320.
26. Vosko SJ, Wilk L, Nusair M. Accurate spin-dependent electron liquid correlation energies for local spin density calculations: a critical analysis. Can J Phys. 1980;58(8):1200-1211.
27. Perdew JP, Wang Y. Accurate and simple analytic representation of the electron-gas correlation energy. Phys Rev B. 1992;45(23): 13244-13249.
28. Delley B. An all-electron numerical method for solving the local density functional for polyatomic molecules. J Chem Phys. 1990;92(1): 508-517.
29. Caimduff FM, Stringer R, Hudson EJ, et al. Superficial photodynamic therapy with topical 5-aminolaevulinic acid for superficial primary and secondary skin cancer. Br J Cancer. 1994;69(3):605-608.
30. Wolf P, Rieger E, Kerl H. Topical photodynamic therapy with endogenous porphyrins after application of 5-aminolevulinic acid. An alternative treatment modality for solar keratoses, superficial squamous cell carcinomas, and basal cell carcinomas? J Am Acad Dermatol. 1993; 28(1):17-21.
31. Rogers LMA, McGivern PG, Butler AR, et al. An efficient synthesis of 5-aminolaevulinic acid (ALA)-containing peptides for use in photodynamic therapy. Tetrahedron. 2005;61(29):6951-6958.
32. Leng QL, Goldgeier J, Zhu P, et al. Histidine-lysine peptides as carriers of nucleic acids. Drug News Perspect. 2007;20(2):77-86.
33. Hadjichristidis N, Iatrou H, Pitsikalis M, et al. Synthesis of well-defined polypeptide-based materials via the ring-opening polymerization of o-amino acid N-carboxyanhydrides. Chem Rev. 2009;109(11): 5528-5578.
34. Foresman JB, Frisch AE. Exploring chemistry with electronic structure methods. Gaussian Inc Pittsburgh PA. 1996;10(2):237-246.
35. Andres J, Beltran J. Quimica teorica computational. Universitat Jaume, Castellon de la Plana Espana. 2000;17(6):161-173.
36. Tang E, Tommaso DD, de Leeuw NH. Accuracy of the microsolvation-continuum approach in computing the pKa and the free energies of formation of phosphate species inaqueous solution. Phys Chem Chem Phys. 2010;12:13804-13815.
37. Mineva T, Parvanov V, Petrov I, et al. Fukui indices from perturbed kohn-sham orbitals and regional softness from Mayer atomic valences. J Phys Chem A. 2001;105(10):1959-1967.
38. Cruz J, Martinez-Aguilera LM, Salcedo R, et al. Reactivity properties of derivatives of 2-imidazoline: an ab initio DFT study. Int J Quant Chem. 2001;85(4-5):546-556.
39. Karelson M, Lobanov VS. Quantum-chemical descriptors in QSAR/ QSPR studies. Chem Rev. 1996;96(3):1027-1044.
40. Lee ES, Shin HJ, Na K, et al. Poly(L-histidine)-PEG block copolymer micelles and pH-induced destabilization. J Control Release. 2003;90(3): 363-374.
41. Schocnteld N, Epstem O, Lahav M, et al. Biosynthetic pathway in lymphocytes of patients with malignant lymphoproliferative disorders. Cancer Lett. 1988;43(1):43-48.
42. Kondo M, Hirota N, Takaoka T, et al. Hemebiosynthetic activities and porphyrin accumulation in normal liver and hepatoma cell lines and rats. Cell Biol Toxicol. 1993;9(1):95-105.
43. El-Sharabasy MMH, El-Wassel AM, Hafez MM, et al. Porphyrin metabolism in some malignant diseases. Br J Cancer. 1992;65(3): 409-412.
44. Kennedy JC, Pottier RH. Endogenous protoporphyrin IX. A clinically useful photosensitizer for photodynamic therapy. J Photochem Photobiol B. 1992;14(4):275-292.
45. Kriegmair M, Baumgartner R, Kneuchel R, et al. Fluorescence detection of neoplastic urothelial lesions following intravesical installation of 5-aminolevulinic acid. Urology. 1994;44(6):836-841.